Pathstone Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Pathstone Family Office’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$12.3M	Buy	24,349 +12,416	+104%	+$6.3M	0.09%	143
2023 Q2	$6.08M	Buy	11,933 +378	+3%	+$193K	0.09%	146
2023 Q1	$6.84M	Sell	11,555 -23,035	-67%	-$13.6M	0.11%	129
2022 Q4	$13.2M	Buy	34,590 +6,386	+23%	+$2.44M	0.11%	142
2022 Q3	$14.3M	Buy	28,204 +23,837	+546%	+$12.1M	0.13%	108
2022 Q2	$2.37M	Buy	4,367 +1,851	+74%	+$1.01M	0.05%	187
2022 Q1	$1.5M	Sell	2,516 -107	-4%	-$63.6K	0.03%	229
2021 Q4	$1.75M	Buy	2,623 +135	+5%	+$90.2K	0.04%	214
2021 Q3	$1.42M	Buy	2,488 +482	+24%	+$275K	0.04%	217
2021 Q2	$1.01M	Buy	2,006 +628	+46%	+$317K	0.03%	269
2021 Q1	$629K	Buy	1,378 +1,128	+451%	+$515K	0.02%	299
2020 Q4	$117K	Buy	250 +136	+119%	+$63.6K	﹤0.01%	351
2020 Q3	$50K	Hold	114	–	–	0.01%	372
2020 Q2	$42K	Hold	114	–	–	0.01%	338
2020 Q1	$32K	Buy	114 +1	+0.9%	+$281	﹤0.01%	363
2019 Q4	$367K	Sell	113 -23	-17%	-$74.7K	﹤0.01%	334
2019 Q3	$40K	Hold	136	–	–	0.01%	301
2019 Q2	$40K	Buy	136 +25	+23%	+$7.35K	﹤0.01%	358
2019 Q1	$30K	Sell	111 -482	-81%	-$130K	﹤0.01%	379
2018 Q4	$133K	Buy	593 +541	+1,040%	+$121K	0.04%	109
2018 Q3	$13K	Sell	52 -45	-46%	-$11.3K	﹤0.01%	154
2018 Q2	$20K	Sell	97 -7	-7%	-$1.44K	0.01%	105
2018 Q1	$21K	Buy	104 +45	+76%	+$9.09K	0.01%	157
2017 Q4	$11K	Sell	59 -203	-77%	-$37.8K	0.01%	105
2017 Q3	$50K	Sell	262 -7	-3%	-$1.34K	0.05%	73
2017 Q2	$47K	Sell	269 -28	-9%	-$4.89K	0.02%	200
2017 Q1	$45K	Buy	+297	New	+$45K	0.02%	188
2016 Q4	–	Sell	-283	Closed	-$45K	–	195
2016 Q3	$45K	Sell	283 -18	-6%	-$2.86K	0.05%	67
2016 Q2	$45K	Sell	301 -75	-20%	-$11.2K	0.04%	59
2016 Q1	$54K	Buy	376 +301	+401%	+$43.2K	0.11%	50
2015 Q4	$11K	Sell	75 -30	-29%	-$4.4K	0.05%	50
2015 Q3	$13K	Buy	+105	New	+$13K	0.04%	71
2014 Q4	–	Sell	-410	Closed	-$50K	–	244
2014 Q3	$50K	Buy	+410	New	+$50K	0.16%	49